Early stage (IA-IB) primary carcinoma of the fallopian tube: Case-control comparison to adenocarcinoma of the ovary

Journal of Gynecologic Oncology

Volumn 22, Issue 1, 2011, Pages 9-17

  Vaysse, Charlotte ^a   Touboul, Cyril ^b   Filleron, Thomas ^a   Mery, Eliane ^a   Jouve, Eva ^c   Leguevaque, Pierre ^d   Morice, Philippe ^b   Leblanc, Eric ^c   Querleu, Denis ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d CHU RANGUEIL   (France)

Author keywords

Case control study; Early stage; Fallopian tube carcinoma; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; PACLITAXEL; PLATINUM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DATA BASE; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LAPAROTOMY; LYMPH NODE METASTASIS; OMENTECTOMY; OUTCOME ASSESSMENT; OVARY ADENOCARCINOMA; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; RECURRENT CANCER; SALPINGOOOPHORECTOMY; UTERINE TUBE CARCINOMA;

EID: 79954522139     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2011.22.1.9     Document Type: Article

References (25)

1. Nordin AJ. Primary carcinoma of the fallopian tube: a 20-year literature review. Obstet Gynecol Surv 1994;49:349-61.
2. Tretarre B, Remontet L, Menegoz F, Mace-Lesec'h J, Grosclaude P, Buemi A, et al. Ovarian cancer: incidence and mortality in France. J Gynecol Obstet Biol Reprod (Paris) 2005;34:154-61.
3. Baekelandt M, Jorunn Nesbakken A, Kristensen GB, Trope CG, Abeler VM. Carcinoma of the fallopian tube. Cancer 2000;89:2076-84.
4. Moore KN, Moxley KM, Fader AN, Axtell AE, Rocconi RP, Abaid LN, et al. Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary. Gynecol Oncol 2007;107:398-403.
5. Wethington SL, Herzog TJ, Seshan VE, Bansal N, Schiff PB, Burke WM, et al. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. Cancer 2008;113:3298-306.
6. Deffieux X, Morice P, Thoury A, Camatte S, Duvillard P, Castaigne D. Pelvic and para-aortic lymphatic involvement in tubal carcinoma: topography and surgical implications. Gynecol Obstet Fertil 2005;33:23-8.
7. Tavassoli FA, Devilee P. Pathology and genetics of tumours of the breast and female genital organs (IARC WHO classification of tumours, No 4). Lyon: IARC Press; 2003.
8. Pectasides D, Pectasides E, Economopoulos T. Fallopian tube carcinoma: a review. Oncologist 2006;11:902-12.
9. Tamimi HK, Figge DC. Adenocarcinoma of the uterine tube: potential for lymph node metastases. Am J Obstet Gynecol 1981;141:132-7.
10. Cormio G, Lissoni A, Maneo A, Marzola M, Gabriele A, Mangioni C. Lymph node involvement in primary carcinoma of the fallopian tube. Int J Gynecol Cancer 1996;6:405-9.
11. di Re E, Grosso G, Raspagliesi F, Baiocchi G. Fallopian tube cancer: incidence and role of lymphatic spread. Gynecol Oncol 1996;62:199-202.
12. Leblanc E, Querleu D, Narducci F, Occelli B, Papageorgiou T, Sonoda Y. Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol 2004;94:624-9.
13. Maxson WZ, Stehman FB, Ulbright TM, Sutton GP, Ehrlich CE. Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy. Gynecol Oncol 1987;26:305-13.
14. Muntz HG, Tarraza HM, Goff BA, Granai GO, Rice LW, Nikrui N, et al. Combination chemotherapy in advanced adenocarcinoma of the fallopian tube. Gynecol Oncol 1991;40:268-73.
15. Morris M, Gershenson DM, Burke TW, Kavanagh JJ, Silva EG, Wharton JT. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 1990;76:1020-4.
16. Barakat RR, Rubin SC, Saigo PE, Lewis JL Jr, Jones WB, Curtin JP. Second-look laparotomy in carcinoma of the fallopian tube. Obstet Gynecol 1993;82:748-51.
17. Peters WA 3rd, Andersen WA, Hopkins MP. Results of chemotherapy in advanced carcinoma of the fallopian tube. Cancer 1989;63:836-8.
18. Pectasides D, Pectasides E, Papaxoinis G, Andreadis C, Papatsibas G, Fountzilas G, et al. Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients. Gynecol Oncol 2009;115:97-101.
19. Roh MH, Kindelberger D, Crum CP. Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol 2009;33:376-83.
20. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 2008;53:127-38.
21. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 2007;31:161-9.
22. Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 2008;26:4160-5.
23. Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 2007;5:35-44.
24. Semmel DR, Folkins AK, Hirsch MS, Nucci MR, Crum CP. Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria. Mod Pathol 2009;22:985-8.
25. Deligdisch L, Penault-Llorca F, Schlosshauer P, Altchek A, Peiretti M, Nezhat F. Stage I ovarian carcinoma: different clinical pathologic patterns. Fertil Steril 2007;88:906-10.